<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: It is widely accepted that the <z:mpath ids='MPATH_270'>adenoma</z:mpath>-<z:mp ids='MP_0002038'>carcinoma</z:mp> sequence represents the process by which most <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e>) arise </plain></SENT>
<SENT sid="1" pm="."><plain>Although gankyrin is overexpressed in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> tissues, its roles in the initiation step of colorectal <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> remain largely unexplored </plain></SENT>
<SENT sid="2" pm="."><plain>AIM: We investigated the expression of gankyrin and stemness factors in human colorectal <z:mpath ids='MPATH_270'>adenomas</z:mpath>, <z:e sem="disease" ids="C0940937" disease_type="Neoplastic Process" abbrv="">precancerous lesions</z:e>, as well as <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> tissues to assess its involvement in colorectal <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Expression of several molecules including gankyrin and certain stemness factors was compared in 50 pairs of <z:mpath ids='MPATH_270'>adenoma</z:mpath> and surrounding <z:mpath ids='MPATH_458'>normal</z:mpath> mucosa using real-time quantitative polymerase chain reaction and in 30 CRC tissues using immunohistochemistry </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: In <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> specimens, expression of CD133, a <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> stem cell marker, was significantly correlated with gankyrin expression </plain></SENT>
<SENT sid="5" pm="."><plain>Gankyrin knockdown decreased the expression of vascular endothelial growth factor (VEGF) and stemness factors such as Nanog and Oct-4 in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cells </plain></SENT>
<SENT sid="6" pm="."><plain>Expression of gankyrin and these stemness factors was significantly higher in <z:mpath ids='MPATH_270'>adenomas</z:mpath> than in the surrounding <z:mpath ids='MPATH_458'>normal</z:mpath> mucosa </plain></SENT>
<SENT sid="7" pm="."><plain>Importantly, a significant correlation was observed between the expression of gankyrin, VEGF, and Nanog in colorectal <z:mpath ids='MPATH_270'>adenomas</z:mpath> </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: In <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> development, gankyrin would control stem cell behavior by regulating the expression of stemness factors </plain></SENT>
</text></document>